Sam Darnold's Healthier Nicotine Pouch Company Targets 10-15% Market Share

Skoka, backed by pro athletes, aims to disrupt Zyn's dominance with science-driven nicotine pouches by 2027.

9 cards · 1m 40s · tap to begin

From · · 1m 40s

Sam Darnold's Healthier Nicotine Pouch Company Targets 10-15% Market Share

Skoka, backed by pro athletes, aims to disrupt Zyn's dominance with science-driven nicotine pouches by 2027.

In brief

Skoka, backed by pro athletes, aims to disrupt Zyn's dominance with science-driven nicotine pouches by 2027. Skoka, a $21m funded company with pro athlete backers, targets 10-15% of the US $5bn nicotine pouch market with ingredient-conscious products by 2027. Originally reported by Inc.

Skoka's Funding and Mission

Skoka, a Canadian ex-hockey player and serial founder, secured $21 million in funding to develop science-backed nicotine pouches targeting the $5 billion US market.

Pro Athlete Backing

Skoka's cap table includes pro athletes like ex-NHL player Sam Gagner, LIV Golf's Anthony Kim, and Super Bowl winner Beau Allen who invested after trying the product.

Scientific Approach

Skoka spent $15 million on proprietary blends rooted in science, targeting 10-15 percent of the ingredient-conscious nicotine user market.

Regulatory Progress

Skoka submitted a PMTA to the US FDA covering 55 products across 11 varieties and five strengths, with two patent applications filed.

Market Target

Skoka focuses on ingredient-conscious nicotine users, who make up a 10-15 percent share of the US $5 billion nicotine pouch market.

Timeline for Launch

Skoka aims to hit shelves in 2027 after submitting regulatory applications and completing scientific testing.

Background on Founder

Dan Aziz, a Canadian ex-hockey player and serial founder, previously sold his supplement brand Premama to Dr. Reddy's Laboratories in 2023.

Competitive Landscape

Skoka competes with Zyn, a Phillip Morris subsidiary that dominates the $5 billion US nicotine pouch market.

Regulatory Path

Skoka has filed two patent applications with the US Patent and Trademark Office to protect its proprietary nicotine pouch formulas.

The bottom line

Skoka, a $21m funded company with pro athlete backers, targets 10-15% of the US $5bn nicotine pouch market with ingredient-conscious products by 2027.

Read the original on Inc

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on skoka and related topics.